Description: Covers 1980 experience under individual loss-of-time policies in the first and second years of the benefit period, and historical data is shown from 1974 forward.

Description: The SOA is releasing this brief report which summarizes the results of the latest National Health Expenditure (NHE) data released by the U.S. Government. This report highlights some of the key elements of the 2018 NHE data and compares them to prior year data and projections.

Description: This tool created graphs of Google's mobility Data. This version of the tool contains global, country-level data through July 31, 2020

Description: The Society's Group Disability Insurance Experience Committee has completed their study of termination experience for the period 2009-2017. Included is a preliminary report, consolidated database (CDB), pivot tables and appendices.

Description: A listing of articles on managed care and health care issues.

Description: Chapter 2 analyzes, in table form, the study's claimant counts and charge totals, broken down by gender, age, diagnosis category, year, and by subscriber vs. dependent status. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: Description and layout of the Group Medical Claims Database from the 1997–1999 Group Medical Insurance Database and Analysis Report.

Description: The Society of Actuaries and LIMRA have sponsored a U.S. Individual Disability Income Persistency Study. The report, authored by Cathy Ho and Steve Elek, presents the results of a study of individual disability income (“IDI”) lapse experience in the United States between observation years 2000 and 2007. This is the first report in a two-part series that will present results of a study conducted jointly by LIMRA and the Society of Actuaries (SOA) and based on data provided by 12 individual disability income insurance writers.

Description: Health care has changed rapidly over the past couple of years. The pandemic has shifted consumer behavior in how and where they receive health care as well as consumer attitudes toward health care. Payers continue to design innovative solutions in responses to their patient’s needs and expectations. These changes in consumer behaviors and the responses by payers are expected to impact both health care cost and utilization. Discuss changes in health care that have emerged due to the pandemic and how they are expected to influence actuarial assumptions. Explore epidemiological models commonly used in the industry, the considerations when using these models, as well as the challenges with regards to gathering and interpreting relevant experience data. By attending this session, you will be able to: Identify shifts in consumer behavior that have emerged from the pandemic and describe how payers are responding to new patient expectations. Discuss how these post-pandemic changes by consumers and payers influence medical spending. Determine which actuarial assumptions are impacted and how and if the impact is expected to be temporary or permanent. Discuss considerations taken by actuaries and challenges faced when modelling actuarial assumptions post pandemic.

Description: This session series is sponsored by Hannover Re Session 1 - COVID-19: Past, Present and Future and Its Impact on Health Products COVID-19 has had an unprecedented impact on the health industry, forcing insurance companies and other risk-sharing entities to re-assess how to write and manage its business going forward. This first of two sessions in the special COVID-19 series will review the impact the pandemic has had on the development, pricing and risk management of health products. The speakers will review COVID-19 mortality and morbidity trends, share possible outlooks for the future of the virus, and analyze how COVID-19 has impacted the pricing strategies and risk management of health business across various markets (e.g., the ACA marketplace, Group Commercial and Medicare). By attending this session, you will be able to explain the latest COVID-19 trends in the US and globally and the resulting impact on mortality and morbidity experience. Attendees will develop a clearer understanding of how the pandemic has impacted the pricing and risk management of health products.